FFOLDAmicus Therapeutics Inc

Amicus Therapeutics Inc

FOLD

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive FOLD chart

Mkt cap
$1.80B
EV/Sales
3.12
P/E ratio
N/A
FY2025 Revenue
$634.21M
EPS (FY2025)
N/A
Gross Margin (FY2025)
88.50%
Profit Margin (FY2025)
-4.27%
Beta
0.53
Div yield
N/A
Sector
Healthcare

No recent filings in cache.

Live FOLD terminal Lician Pro · $19.99/mo or $149/yr Peer financials on Pro API free 100/day Compare AAPL vs MSFT

FOLD — Amicus Therapeutics Inc · rev $634.2M

Amicus Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full FOLD income, balance, and cash tables.

Revenue$634.2M
Net Income-$27.1M
Total Assets$949.9M
Total Debt$392.7M
Free Cash Flow$29.8M

† Total Debt: Derived from long-term debt only (no total or short-term debt stored).

FOLD FAQ

What industry is FOLD in?

Amicus Therapeutics Inc (FOLD) is a biotechnology company in the Healthcare sector.

What are FOLD's latest revenue and net income?

Latest cached Amicus Therapeutics Inc (FOLD) revenue for Dec 31, 2025 was $634.2M. Net income was -$27.1M. Statements: https://lician.com/financials/fold

What is FOLD's market cap?

Amicus Therapeutics Inc (FOLD) market capitalization is $1.80B on the latest cached snapshot.